🤝 Join us for our online Annual General Meeting on Wednesday 11th November, 6.30-8pm! Register here: forms.cloud.microsoft/Pages/…

🏆 Tonight’s the night! 🏆 We’re incredibly proud that the Immuno-Oncology Clinical Network (IOCN) has been shortlisted for the HSJ Patient Safety Awards 2026 in the Patient Safety Education and Training Award category. Being shortlisted is fantastic recognition of the work that goes into improving education, knowledge and confidence around immunotherapy and immune-related adverse events — and, ultimately, supporting safer care for patients. It also reflects the commitment of the incredible multidisciplinary community that contributes to, supports and engages with the IOCN across the UK. 💙 We’re looking forward to joining colleagues from across healthcare at tonight’s awards ceremony and celebrating the brilliant work being done to improve patient safety. 🤞 Wish us luck! #HSJPatientSafety #HSJPatientSafetyAwards #PatientSafety #ImmunoOncology #IOCN #Immunotherapy #CancerCare #HealthcareEducation #NHS @HSJ_Awards @AOlssonBrown @RickyFrazer1 @JohnsonA_D – at Lilleshall, England

🎓 Day 2 of the IO Champions Masterclass is underway! After a fantastic first day of learning, discussion, networking and plenty of shared experiences, our IO Champions are back for Day 2 in Birmingham! Yesterday really demonstrated what this Masterclass is all about – bringing together healthcare professionals from across the UK and Ireland, connecting different professions and specialties, and creating opportunities to learn from each other as well as from our fantastic faculty. Today we’re building on those conversations with another packed programme exploring the complexities of Immuno-Oncology and immune-related toxicity management. There may also have been a little socialising last night… 👀😂 Ready for Day 2! 🙌 #IOChampions #IOCN #ImmunoOncology #Immunotherapy #CancerCare #HealthcareEducation #MultidisciplinaryWorking @AOlssonBrown @RickyFrazer1

🧠 Neurological Toxicities | IO Champions Masterclass We’re continuing our multidisciplinary journey through immune-related toxicities with Dr Aisling Carr, Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, exploring the complex world of neurological toxicities associated with immunotherapy. Neurological immune-related adverse events may be relatively uncommon, but they can be complex, potentially severe and present in many different ways – making early recognition, specialist input and close collaboration between oncology and neurology incredibly important. A key focus of today’s session is the opportunity for collaborative working between neurologists and oncologists – bringing together expertise from both specialties to support diagnosis, investigation and management of these challenging toxicities. A huge thank you to Dr Aisling Carr for sharing her expertise and experience with our IO Champions in Birmingham today! 👏 #IOChampions #IOCN #ImmunoOncology #Immunotherapy #Neurology #Neurotoxicity #CancerCare #MultidisciplinaryWorking #Oncology #irAEs @AOlssonBrown @RickyFrazer1 @immunobuddies @IOClinicalNet

🔬 New and Novel Immunotherapeutics | IO Champions Masterclass We’re looking to the future of Immuno-Oncology this morning in Birmingham as Dr Adam Januszewski and Professor Anna Olsson-Brown take our IO Champions through the rapidly evolving landscape of new and novel immunotherapeutics. Their session explores: 🧬 The diversity of bispecifics through the lens of lung oncology 🎯 Antibody Drug Conjugates (ADCs) 🔭 The future of immunotherapeutics With the range and complexity of cancer treatments continuing to expand, understanding what is coming next – and what these developments could mean for patients and the teams caring for them – is an important part of preparing our IO Champions for the future. A fascinating look at innovation beyond established immune checkpoint inhibitors, the emerging therapeutic landscape and where Immuno-Oncology could be heading next. A huge thank you to @AdamJanuszewski and @AOlssonBrown for sharing their expertise with our Champions! 👏 #IOChampions #IOCN #ImmunoOncology #Immunotherapy #CancerCare #Oncology #ADCs #Bispecifics #CancerResearch #HealthcareEducation

📍 Just how far are our IO Champions travelling from? This weekend, Birmingham becomes the meeting point for healthcare professionals working in Immuno-Oncology from across the UK and Ireland. 🇬🇧🇮🇪 From Inverness and Aberdeen in the north to Devon, Southampton and Sussex in the south – and from Cork and Limerick to Maidstone – our first IO Champions Masterclass is bringing together colleagues from an incredible range of locations. One of the key aims of the IO Champions Masterclass is not simply to deliver education, but to help build a connected community of people who can take that learning, enthusiasm and network back to their own teams and regions. Seeing the geographical spread of our Champions really brings that ambition to life. Welcome to Birmingham, IO Champions! 🎓 #IOChampions #IOCN #ImmunoOncology #Immunotherapy #CancerCare #Oncology #HealthcareEducation #MultidisciplinaryWorking @AOlssonBrown @RickyFrazer1 @immunobuddies

🌟 What is the IO Champions Masterclass? This weekend, the Immuno-Oncology Clinical Network (IOCN) is bringing together healthcare professionals from across the UK for two days dedicated to learning, sharing and collaboration in Immuno-Oncology. The IO Champions Masterclass has been designed to support and develop healthcare professionals with a passion for improving the care of patients receiving immunotherapy. Across two packed days in Birmingham, our IO Champions will learn from experts from across oncology and a wide range of specialist disciplines, exploring everything from the fundamentals and future of immune checkpoint inhibitors to novel therapies, service development and the recognition and management of complex immune-related toxicities. But the Masterclass is about more than education. We want to bring people together. By connecting colleagues working in Immuno-Oncology across different professions, specialties, hospitals and regions, we hope to create a community of IO Champions who can share knowledge, learn from one another and take ideas and expertise back to their own teams and services. Topics across the two days include: 🔬 Immune checkpoint inhibitors – where we are and where we're going 🧬 Novel and emerging therapies, including BiTEs, ADCs, TILs and vaccines 🏥 Developing effective Immuno-Oncology services 💊 Pharmacology and immunosuppression 🫀🫁 Complex immune-related toxicities across multiple specialties 🤝 The role of the multidisciplinary team 📊 Metrics, outcomes and real-world data 💡 Sharing experience, challenges and best practice Ultimately, our aim is simple: to strengthen the Immuno-Oncology community and help healthcare professionals deliver the best possible care for patients receiving immunotherapy. We can't wait to welcome our first group of IO Champions to Birmingham! 🎓 #IOChampions #ImmunoOncology #IOCN #Immunotherapy #CancerCare #Oncology #HealthcareEducation #MultidisciplinaryWorking

We are thrilled to kick off our IOCN Masterclass in Birmingham with our fantastic IO toxicity community! @RickyFrazer1 @AOlssonBrown @immunobuddies #IOCN #IOMasterclass

Limited places remaining to join us at the hugely popular "Advancing the Management of Immunotherapy Toxicities Through Case Conundrums" conference! 📅 Friday 16th October 2026 📍 Vermont Hotel, Newcastle-Upon-Tyne 💷 £150pp This CPD-accredited event brings together experts and healthcare professionals to explore real-world immunotherapy toxicity cases, share best practice, and learn through interactive discussion. ✅ 6.5 hours CPD ✅ Expert-led sessions ✅ Cutting-edge topics ✅ Interactive learning & networking 👉 Secure your place or submit your abstract via the link/QR code tinyurl.com/r3shtef4

🔴🟡🔴 Join the IOCN at ESMO Congress 2026! Cutaneous Squamous Cell Carcinoma: An Illustrative Case for Immune Checkpoint Inhibitors An Independent meeting held adjacent to ESMO Congress 2026, Madrid, Spain. 🔴🟡🔴 📍 Radisson RED Madrid 📅 Friday 23 October 2026 🕡 18:30–22:00 (CEST) 💻 Face-to-face or online attendance available Whether you're attending ESMO Congress in Madrid or joining remotely from anywhere in the world, the Immuno-Oncology Clinical Network (IOCN) invites you to an evening of expert discussion exploring the evolving role of immune checkpoint inhibitors in the management of cutaneous squamous cell carcinoma. Hear from leading UK experts including: 👉 Prof Anna Olsson-Brown 👉 Prof Ricky Frazer 👉 Associate Professor Will Ince 👉 Dr Heather Shaw Topics include: 🔵 Mechanism of action of immune checkpoint inhibitors 🔵 Management in metastatic disease 🔵 Complex clinical cases 🔵 Adjuvant immunotherapy 🔵 Live expert panel discussion and audience Q&A Those attending in Madrid are also invited to stay for a buffet, refreshments and networking following the educational programme. 🥘🍹 ✔ Free registration ✔ Attend in person or online ✔ Open to healthcare professionals Register today to secure your place (limited spaces): Cutaneous Squamous Cell Carcinoma: An Illustrative Case for Immune Checkpoint – Fill in form

🔴🟡🔴 Join the IOCN at ESMO Congress 2026! Cutaneous Squamous Cell Carcinoma: An Illustrative Case for Immune Checkpoint Inhibitors An Independent meeting held adjacent to ESMO Congress 2026, Madrid, Spain. 🔴🟡🔴 📍 Radisson RED Madrid 📅 Friday 23 October 2026 🕡 18:30–22:00 (CEST) 💻 Face-to-face or online attendance available Whether you're attending ESMO Congress in Madrid or joining remotely from anywhere in the world, the Immuno-Oncology Clinical Network (IOCN) invites you to an evening of expert discussion exploring the evolving role of immune checkpoint inhibitors in the management of cutaneous squamous cell carcinoma. Hear from leading UK experts including: 👉 Prof Anna Olsson-Brown 👉 Prof Ricky Frazer 👉 Associate Professor Will Ince 👉 Dr Heather Shaw Topics include: 🔵 Mechanism of action of immune checkpoint inhibitors 🔵 Management in metastatic disease 🔵 Complex clinical cases 🔵 Adjuvant immunotherapy 🔵 Live expert panel discussion and audience Q&A Those attending in Madrid are also invited to stay for a buffet, refreshments and networking following the educational programme. 🥘🍹 ✔ Free registration ✔ Attend in person or online ✔ Open to healthcare professionals Register today to secure your place (limited spaces): Cutaneous Squamous Cell Carcinoma: An Illustrative Case for Immune Checkpoint – Fill in form @IOClinicalNet @immunobuddies @ACPUK @BOPACommittee @UKONSmember @RCPhysicians @AOlssonBrown @RickyFrazer1 @DrHMShaw @will_oncology

The Immunobuddies Podcast Patient Video Series is now live! Every patient deserves access to clear, trusted information—not just during their clinic appointment, but whenever they need it. Walking through the consent form can be overwhelming for all, with patients needing to understand every potential benefit and risk. We’re delighted to launch The Immunobuddies Podcast Patient Video Podcast Series: a free educational resource designed to support patients and their loved ones throughout their immunotherapy journey. Developed with input from hundreds of patients, caregivers and healthcare professionals from across the UK and , these bite-sized videos are presented by Prof Anna Olsson-Brown and Prof Ricky Frazer answering the questions we hear most often in clinics in a clear, practical and patient-friendly way. 🎥 Watch the full series now at: 🌐 theimmunobuddies.com Find the full resources at: 🌐 lnkd.in/eDRaBEX7 Just scroll to the bottom of the page To help make these resources available to as many patients as possible, we have created: 📌 A hospital poster with a QR code that can be displayed in oncology clinics, treatment units and waiting areas. 📖 A printable patient leaflet that can be given to patients at the start of their immunotherapy treatment. 📌Timestamps to navigate to a particular question Our goal is simple: to ensure every patient receiving immunotherapy has access to accurate, evidence-based information whenever they need it. If you work in cancer care or if you support those that do, we’d be incredibly grateful if you could help us spread the word by: ✅ Displaying the poster in your department ✅ Printing the patient leaflet for your patients ✅ Sharing the videos with colleagues and patients ✅ Sharing this post within your network Thank you to everyone who helped shape these resources—we hope they’ll make a real difference to patients and families. Please share this post to help us reach as many people as possible. 🌐 theimmunobuddies.com

🩷 Supporting Education Across the UK As part of #CancerImmunotherapyMonth, we're proud to highlight educational initiatives that are supported and endorsed by the Immuno-Oncology Clinical Network (IOCN). We believe that improving patient outcomes begins with supporting healthcare professionals through accessible, high-quality education and shared learning. The IOCN are proud to support and endorse: 🎓 National IO Education Forum A free monthly national virtual education meeting bringing together approximately 100 multidisciplinary healthcare professionals involved in immunotherapy care from across the UK. 🎙️ The Immunobuddies An innovative educational platform translating complex immunotherapy science into practical, real-world learning. Find out more below. Together, these initiatives help strengthen education, collaboration and patient care across the immuno-oncology community. Supporting those receiving immunotherapy by supporting those delivering it. #ImmunotherapyAwarenessMonth #IOCN #Education #Immunotherapy #SharedLearning #CancerCare #Immunobuddies #NationalIOEducationForum @AOlssonBrown @RickyFrazer1 @JohnsonA_D @DTM_xx @Nick_G89 @brentocarrigan @will_oncology @Youngdr100 @TrudyGuinan @UKONSmember @BOPACommittee @OncoDailyIO @ACPUK @myESMO @ASCO @oncologyforum @OncologyNT @simplyoncology

🩷 Education in Action As part of #CancerImmunotherapyMonth, we're highlighting the IOCN's commitment to education and shared learning. Through our growing educational programme, we aim to support healthcare professionals delivering immunotherapy by providing practical, relevant and accessible learning opportunities. Our webinar series include: ❓ Ask A Question Interactive monthly webinars where cases and questions are discussed by an expert panel. 💡 New & Novel Exploring emerging immunotherapies and associated toxicities, including CRS, HLH and ICANS. 🌟 Spotlight Featuring cutting-edge developments, expert insights and practical approaches in immuno-oncology. 🏥 Service Showcase Showcasing innovative immunotherapy services and best practice from across the UK. In addition, we host two face-to-face "Advance the Management of Immunotherapy Toxicities Through Case Conundrums" study days each year, bringing together multidisciplinary colleagues from across the UK to discuss complex clinical cases and share learning. We are also proud to support and promote educational initiatives delivered by colleagues and partner organisations nationwide. Discover more about all our education offerings and register via our website: ioclinicalnetwork.co.uk/educ… Together, we are building a connected and informed immuno-oncology community. #ImmunotherapyAwarenessMonth #IOCN #Immunotherapy #Education #CancerCare #SharedLearning @AOlssonBrown @RickyFrazer1 @JohnsonA_D @DTM_xx @Nick_G89 @brentocarrigan @will_oncology @Youngdr100 @TrudyGuinan @UKONSmember @BOPACommittee @OncoDailyIO @ACPUK @myESMO @ASCO @oncologyforum @OncologyNT @simplyoncology

🟢 Clinical Support in Development As part of #ImmunotherapyAwarenessMonth, we're highlighting ongoing work within the Immuno-Oncology Clinical Network (IOCN) aimed at supporting healthcare professionals managing immune-related adverse events (irAEs). Two new guidance documents are currently in development: 🦠 Antimicrobial prophylaxis for patients receiving immunosuppression Providing practical recommendations to support infection prevention in patients requiring immunosuppressive therapies for the management of immunotherapy toxicities. 🦴 Bone protection guidance for patients receiving steroids in response to immunotherapy toxicities Supporting best practice to reduce the risk of steroid-induced bone loss and associated complications. These projects are being developed through multidisciplinary collaboration and reflect the IOCN's commitment to providing practical, evidence-informed resources to support healthcare professionals and improve patient care. More information will be shared as these projects progress. #ImmunotherapyAwarenessMonth #IOCN #Immunotherapy #ClinicalSupport #PatientSafety #irAEs @AOlssonBrown @RickyFrazer1 @JohnsonA_D @DTM_xx @Nick_G89 @brentocarrigan @will_oncology @Youngdr100 @TrudyGuinan @UKONSmember @BOPACommittee @OncoDailyIO @ACPUK @myESMO @ASCO @oncologyforum @OncologyNT @simplyoncology

📍 We’re excited to be exhibiting at the UK Oncology Forum 2026 at the Harrogate Convention Centre! If you're attending, be sure to visit the Immuno-Oncology Clinical Network (IOCN) exhibition stand to learn more about our work supporting healthcare professionals in the delivery of immunotherapy services and the management of immune-related adverse events. 👋 Come and say hello, meet the team, and discover how the IOCN is helping to connect, educate, and support the oncology community across the UK. We look forward to seeing colleagues, sharing ideas, and building new collaborations throughout the conference. #UKOncologyForum2026 #UKOF26 #IOCN #ImmunoOncology #CancerCare #OncologyNursing #CancerServices #Collaboration #Harrogate #OncologyCommunity @AOlssonBrown @DTM_xx @Nick_G89 @immunobuddies

🫀 Advancing Cardio-Oncology As part of hashtag#CancerImmunotherapyMonth, we're highlighting the collaborative work of the Immuno-Oncology Clinical Network (IOCN) in improving the recognition and management of immune-related cardiac toxicities. In 2024, the IOCN, in collaboration with the British Cardio-Oncology Society (BCOS), published the Joint Consensus Statement: 📖 Baseline Cardiac Assessment in Individuals Receiving Immune Checkpoint Inhibitors The document provides practical recommendations to support clinicians in implementing baseline cardiac assessment and promoting consistent, evidence-informed practice across the UK. Building on this work, a multidisciplinary working group is currently developing a further consensus statement focused on the management of immune-related cardiac toxicities. 🫀 Expected release: Autumn/Winter 2026 Through continued collaboration between oncology and cardiology specialists, we aim to strengthen patient safety, improve outcomes and support healthcare professionals delivering immunotherapy. Together, we are helping shape the future of cardio-oncology. #ImmunotherapyAwarenessMonth #IOCN #CardioOncology #PatientSafety #Immunotherapy #CancerCare #UKOF26 #BCOS @AOlssonBrown @RickyFrazer1 @JohnsonA_D @DTM_xx @Nick_G89 @brentocarrigan @will_oncology @Youngdr100 @TrudyGuinan @UKONSmember @BOPACommittee @OncoDailyIO @ACPUK @myESMO @ASCO @oncologyforum @OncologyNT @simplyoncology

🟡 Building a National Framework for irAE Management As part of #CancerImmunotherapyMonth, we're highlighting ongoing work being led through the Immuno-Oncology Clinical Network (IOCN). Following concerns regarding inequitable access to immunosuppressive medicines used in the management of immune checkpoint inhibitor (ICI) toxicities, the IOCN and UKSACT Board engaged with NHS England in November 2025 to discuss the challenges faced across the UK. This work led to the establishment of a national multidisciplinary working group tasked with developing a consensus framework for the comprehensive management of immune-related adverse events (irAEs). In May 2026, experts from across the UK came together at the IOCN two-day meeting in London to begin shaping this work through a series of collaborative workshops. Our shared aim is to ensure that patients receive the greatest possible benefit from immunotherapy while reducing the risk of serious toxicity and treatment-related complications through consistent, evidence-informed pathways of care. By working together nationally, we hope to: 🟡 Improve equity of access 🟡 Strengthen patient safety 🟡 Improve patient outcome 🟡 Support healthcare professionals delivering immunotherapy 🟡 Promote consistent, evidence-informed management of irAEs ✍ We are now bringing together the outputs from these workshops to begin developing a proposed consensus framework. Together, we are helping shape the future of immunotherapy toxicity management. #ImmunotherapyAwarenessMonth #IOCN #irAEs #PatientSafety #ImmunoOncology #PolicyAndGovernance #UKOF26 @AOlssonBrown @RickyFrazer1 @JohnsonA_D @DTM_xx @Nick_G89 @brentocarrigan @will_oncology @Youngdr100 @TrudyGuinan @UKONSmember @BOPACommittee @OncoDailyIO @ACPUK @myESMO @ASCO @oncologyforum @OncologyNT @simplyoncology